Valencell Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
2ndary - Private
- Investors
-
11
Valencell General Information
Description
Developer of biometric sensor technology designed to make chronic disease management easier with wearable biometrics. The company's technology continuously and accurately measures real-time biometric and physiological data and employs active signal characterization, enabling users to have integrated and validated heart rate sensors to generate actionable insights.
Contact Information
Website
www.valencell.comCorporate Office
- 4601 Six Forks Road
- Suite 103
- Raleigh, NC 27609
- United States
Corporate Office
- 4601 Six Forks Road
- Suite 103
- Raleigh, NC 27609
- United States
Valencell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Secondary Transaction - Private | 26-Apr-2023 | Completed | Generating Revenue | |||
| 11. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series F) | 23-Jan-2020 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 28-Jun-2018 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series E) | 13-Jun-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series D) | 07-Mar-2016 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 16-Jun-2014 | Completed | Generating Revenue | |||
| 5. Grant | Completed | Generating Revenue | ||||
| 4. Later Stage VC (Series B) | 27-Aug-2013 | $4M | $10.6M | Completed | Generating Revenue | |
| 3. Later Stage VC (Series B) | 20-Jun-2011 | $5.52M | $6.57M | Completed | Generating Revenue |
Valencell Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F1 | ||||||||
| Series F | ||||||||
| Series E1 | ||||||||
| Series E | ||||||||
| Series D1 | ||||||||
| Series D | ||||||||
| Series C1 | ||||||||
| Series C | ||||||||
| Series B1 | 2,337,793 | $0.001000 | $0.14 | $1.72 | $1.72 | 1x | $1.72 | 7.08% |
| Series B | 880,067 | $0.001000 | $0.14 | $1.72 | $1.72 | 1x | $1.72 | 2.67% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Valencell Comparisons
Industry
Financing
Details
Valencell Competitors (2)
One of Valencell’s 2 competitors is Shimmer Research, a Corporation company based in Dublin, Ireland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Shimmer Research | Corporation | Dublin, Ireland | ||||
| APDM Wearable Technologies | Private Equity-Backed | Portland, OR |
Valencell Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Valencell Patents
Valencell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4240232-A1 | Systems, methods and apparatus for generating blood glucose estimations using real-time photoplethysmography data | Pending | 30-Dec-2020 | ||
| JP-2024501861-A | Systems, methods and devices for generating estimated blood glucose levels from real-time photoplethysmography data | Active | 30-Dec-2020 | ||
| JP-7580613-B2 | Systems, methods and apparatus for generating estimated blood glucose levels from real-time photoplethysmography data | Active | 30-Dec-2020 | ||
| EP-4240232-A4 | Systems, methods and apparatus for generating blood glucose estimations using real-time photoplethysmography data | Pending | 30-Dec-2020 | ||
| JP-2025037863-A | Systems, methods and apparatus for generating estimated blood glucose levels from real-time photoplethysmography data | Pending | 30-Dec-2020 | A61B5/0205 |
Valencell Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Valencell Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CBC Partners | Lender/Debt Provider | Minority | ||
| Halma | Corporation | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Sonion | PE-Backed Company | Minority |
Valencell FAQs
-
When was Valencell founded?
Valencell was founded in 2006.
-
Where is Valencell headquartered?
Valencell is headquartered in Raleigh, NC.
-
What is the size of Valencell?
Valencell has 16 total employees.
-
What industry is Valencell in?
Valencell’s primary industry is Electronic Equipment and Instruments.
-
Is Valencell a private or public company?
Valencell is a Private company.
-
What is Valencell’s current revenue?
The current revenue for Valencell is .
-
How much funding has Valencell raised over time?
Valencell has raised $45.1M.
-
Who are Valencell’s investors?
CBC Partners, Halma, , , and Sonion are 5 of 11 investors who have invested in Valencell.
-
Who are Valencell’s competitors?
Shimmer Research and APDM Wearable Technologies are competitors of Valencell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
